Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Stoke Therapeutics granted stock options to purchase an aggregate of 70,950 shares to seven new employees as an employment inducement under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $32.13 per share, which is equal to the closing price of the company's common stock on the grant date.
Key figures
- Exercise price
- 32.13
- Shares underlying options
- 70950
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.